Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec;32(12):2693-2697.
doi: 10.1038/s41375-018-0148-3. Epub 2018 Jun 6.

A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial

A K Burnett  1 , R K Hills  2 , O J Nielsen  3 , S Freeman  4 , A Ali  5 , P Cahalin  6 , A Hunter  7 , I F Thomas  8 , N H Russell  9
Affiliations

A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial

A K Burnett et al. Leukemia. 2018 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Outcome data. a Overall survival, b relapse-free survival, c cumulative incidence of relapse and d survival censored at stem cell transplantation
See this image and copyright information in PMC

References

    1. Burnett AK. Treatment of acute myeloid leukemia: are we making progress? Hematol Am Soc Hematol Educ Program. 2012;2012:1–6. doi: 10.1182/asheducation.V2012.1.1.3797038. - DOI - PubMed
    1. Lee JH, Joo YD, Kim H, Bae SH, Kim MK, Zang DY, et al. A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia. Blood. 2011;118:3832–41. doi: 10.1182/blood-2011-06-361410. - DOI - PubMed
    1. Burnett A, Wetzler M, Lowenberg B. Therapeutic advances in acute myeloid leukemia. J Clin Oncol. 2011;29:487–94. doi: 10.1200/JCO.2010.30.1820. - DOI - PubMed
    1. Burnett AK, Russell NH, Hills RK, Hunter AE, Kjeldsen L, Yin J, et al. Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the medical research council AML15 trial. J Clin Oncol. 2013;31:3360–8. doi: 10.1200/JCO.2012.47.4874. - DOI - PubMed
    1. Kantarjian H, Gandhi V, Cortes J, Verstovsek S, Du M, Garcia-Manero G, et al. Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia. Blood. 2003;102:2379–86. doi: 10.1182/blood-2003-03-0925. - DOI - PubMed

Publication types

Supplementary concepts